These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12663605)

  • 1. Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macrovascular complications.
    Kimura F; Hasegawa G; Obayashi H; Adachi T; Hara H; Ohta M; Fukui M; Kitagawa Y; Park H; Nakamura N; Nakano K; Yoshikawa T
    Diabetes Care; 2003 Apr; 26(4):1246-50. PubMed ID: 12663605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus.
    Ukkola O; Erkkilä PH; Savolainen MJ; Kesäniemi YA
    J Intern Med; 2001 May; 249(5):451-9. PubMed ID: 11350569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients.
    Adachi T; Inoue M; Hara H; Maehata E; Suzuki S
    J Endocrinol; 2004 Jun; 181(3):413-7. PubMed ID: 15171689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two variants of extracellular-superoxide dismutase: relationship to cardiovascular risk factors in an unselected middle-aged population.
    Marklund SL; Nilsson P; Israelsson K; Schampi I; Peltonen M; Asplund K
    J Intern Med; 1997 Jul; 242(1):5-14. PubMed ID: 9260561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface.
    Adachi T; Yamada H; Yamada Y; Morihara N; Yamazaki N; Murakami T; Futenma A; Kato K; Hirano K
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):235-9. PubMed ID: 8546689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.
    Möllsten A; Jorsal A; Lajer M; Vionnet N; Tarnow L
    Diabetologia; 2009 Dec; 52(12):2590-3. PubMed ID: 19834686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy.
    Zitouni K; Nourooz-Zadeh J; Harry D; Kerry SM; Betteridge DJ; Cappuccio FP; Earle KA
    Diabetes Care; 2005 Jul; 28(7):1698-703. PubMed ID: 15983322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
    Mohammedi K; Bellili-Muñoz N; Marklund SL; Driss F; Le Nagard H; Patente TA; Fumeron F; Roussel R; Hadjadj S; Marre M; Velho G
    Cardiovasc Diabetol; 2015 Jan; 14():845. PubMed ID: 25855220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired synthesis is not the reason for decreased activity of extracellular superoxide dismutase in patients with diabetes.
    Ciechanowski K; Kedzierska K; Gołembiewska E; Safranow K; Bober J; Domański L; Rózański J; Myślak M
    Arch Med Res; 2005; 36(2):148-53. PubMed ID: 15847948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes.
    Tamai M; Furuta H; Kawashima H; Doi A; Hamanishi T; Shimomura H; Sakagashira S; Nishi M; Sasaki H; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 2006 Feb; 71(2):140-5. PubMed ID: 15990193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An arginine-213 to glycine mutation in human extracellular-superoxide dismutase reduces susceptibility to trypsin-like proteinases.
    Adachi T; Morihara N; Yamazaki N; Yamada H; Futenma A; Kato K; Hirano K
    J Biochem; 1996 Jul; 120(1):184-8. PubMed ID: 8864862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy.
    Kuo CW; Chen HL; Tu MY; Chen CM
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F32-F41. PubMed ID: 30303710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
    Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
    Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum markers of oxidative stress and severity of diabetic retinopathy.
    Hartnett ME; Stratton RD; Browne RW; Rosner BA; Lanham RJ; Armstrong D
    Diabetes Care; 2000 Feb; 23(2):234-40. PubMed ID: 10868837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shortened Activated Partial Thromboplastin Time and Increased Superoxide Dismutase Levels Are Associated with Type 2 Diabetes Mellitus.
    Fu G; Yan Y; Chen L; Zhang M; Ming L
    Ann Clin Lab Sci; 2018 Jul; 48(4):469-477. PubMed ID: 30143488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.